EP Patent

EP1354882A1 — Dipeptidyl peptidase iv inhibitor

Assigned to KH Neochem Co Ltd · Expires 2003-10-22 · 23y expired

What this patent protects

A compound represented by general formula (I): A-B-D <wherein A represents a substituted or unsubstituted 1-pyrrolidinyl group, a substituted or unsubstituted 3-thiazolidinyl group, a substituted or unsubstituted 1-oxo-3-thiazolidinyl group, or the like; B represents a)…

USPTO Abstract

A compound represented by general formula (I): A-B-D <wherein A represents a substituted or unsubstituted 1-pyrrolidinyl group, a substituted or unsubstituted 3-thiazolidinyl group, a substituted or unsubstituted 1-oxo-3-thiazolidinyl group, or the like; B represents a) a group represented by -(C(R 1 )(R 2 )) k CO- (wherein k represents an integer of from 1 to 6, R 1 and R 2 may be the same or different and each represents a hydrogen atom, a hydroxyl group, a halogen atom, or the like) or the like; D represents -U-V [wherein U represents a substituted or unsubstituted piperazinediyl group or the like, V represents -E-R 7 (wherein E represents a single bond, -CO-, -C(=O)O-, or -SO 2 -; R 7 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or the like)] > or a pharmacologically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1354882A1
Jurisdiction
EP
Classification
Expires
2003-10-22
Drug substance claim
No
Drug product claim
No
Assignee
KH Neochem Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.